Monday, December 21, 2020 4:57:49 PM
Mon, December 21, 2020, 4:30 PM EST
Acquisition Will Expand Company's Global Footprint and Sets Stage for U.S. Growth
ALMATY, KAZAKHSTAN / ACCESSWIRE / December 21, 2020 / Freedom Holding Corp. (NASDAQ:FRHC) (the "Company") today announced that the Financial Industry Regulatory Authority ("FINRA") has approved the continuing membership application filed by Prime Executions, Inc. ("Prime Executions"), a Delaware corporation, that will permit the Company to complete the acquisition of Prime Executions. The transaction is expected to close by the first week of January 2021. Prime Executions is a broker dealer registered with the U.S. Securities and Exchange Commission and member of the New York Stock Exchange ("NYSE") where it acts as an agency only broker dealer operating from the floor of the exchange. It is also a member of NASDAQ, FINRA and SIPC.
Commenting on the acquisition, Company CEO, Timur Turlov stated, "We are pleased to receive the FINRA approval necessary to allow us to complete the acquisition of Prime Executions, which has a sterling reputation at the New York Stock Exchange, and we look forward to working with the strong team of brokers and market experts that have been delivering exceptional service to clients for the past 29 years. The acquisition of Prime Executions is an important milestone for Freedom Holding, as it will give us a foothold in the U.S. markets that will benefit our clients by assuring them cost efficient and timely execution of U.S. market trades. Also, we expect the addition of Prime Executions will allow us to continue expanding our business by making available to both U.S. and Eurasian market participants the best cross-market financial opportunities."
https://finance.yahoo.com/news/freedom-holding-corp-set-acquire-213000484.html
JMHO. DYODD. "An investment in knowledge pays the best interest." - Benjamin Franklin
Recent FRHC News
- Freedom Holding Corp. CEO, Timur Turlov, to Deliver Keynote Speech at LD Micro Inaugural New York Investor Conference • Business Wire • 04/01/2024 11:30:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/06/2024 09:01:17 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/06/2024 06:57:50 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/29/2024 12:00:24 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/13/2024 01:00:18 PM
- Freedom Holding Corp. Reports Third Quarter Fiscal Year 2024 Financial Results • Business Wire • 02/12/2024 02:35:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 02/09/2024 10:11:01 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/25/2024 09:16:05 PM
- Freedom Holding Corp. Announces Completion of External Review of Allegations Made in Short-Seller Report • Business Wire • 01/25/2024 09:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/01/2023 03:15:32 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/20/2023 09:05:16 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 11/17/2023 10:29:19 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 11/17/2023 10:22:26 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/08/2023 11:30:48 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/06/2023 12:55:49 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 11/03/2023 05:47:26 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 11/03/2023 12:36:25 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/12/2023 09:06:19 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 10/10/2023 01:10:53 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 09/11/2023 01:56:22 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 09/11/2023 01:54:57 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/24/2023 05:43:52 PM
- Rosca Scarlato Investor Lawyers Investigating • PR Newswire (US) • 08/16/2023 07:10:00 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM